Clinical activity and safety of Pembrolizumab in Ipilimumab pre-treated patients with uveal melanoma

Background: Untreated metastatic uveal melanoma (UM) carries a grave prognosis. Unlike cutaneous melanoma (CM), there are no established treatments known to significantly improve outcomes for a meaningful proportion of patients. Inhibition of the PD1–PDL1 axis has shown promise in the management of...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Oncoimmunology
Main Authors: Karydis, Ioannis, Chan, Pui Ying, Wheater, Matthew, Arriola, Edurne, Szlosarek, Peter W., Ottensmeier, Christian H.
Formato: Artigo
Idioma:Inglês
Publicado em: Taylor & Francis 2016
Assuntos:
Original Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4910726/
https://ncbi.nlm.nih.gov/pubmed/27467964
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/2162402X.2016.1143997
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados